← FDA DRUG APPROVALS

FDA ANDA · ANDA076278

FLECAINIDE ACETATE

Sponsor: HIKMA

APPLICATION
ANDA076278
TYPE
ANDA
ORIGINAL APPROVAL
2003-01-14
LATEST ACTION
2015-02-17
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

FLECAINIDE ACETATEPrescription
FLECAINIDE ACETATE 50MG · TABLET · ORAL
FLECAINIDE ACETATEPrescription
FLECAINIDE ACETATE 100MG · TABLET · ORAL
FLECAINIDE ACETATEPrescription
FLECAINIDE ACETATE 150MG · TABLET · ORAL

Approval history

2015-02-17Manufacturing (CMC) · Supplement 5AP
2007-11-07Labeling · Supplement 3AP
2003-01-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →